Insider Transactions in Q2 2025 at Axon Enterprise, Inc. (AXON)
Insider Transaction List (Q2 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 26
2025
|
Brittany Bagley COO & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,250
-1.08%
|
$1,003,750
$803.95 P/Share
|
Jun 17
2025
|
Joshua Isner PRESIDENT |
SELL
Open market or private sale
|
Direct |
905
-0.34%
|
$702,280
$776.39 P/Share
|
Jun 16
2025
|
Joshua Isner PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
680
-0.25%
|
$530,400
$780.63 P/Share
|
Jun 13
2025
|
Jennifer H Mak Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
75
-0.49%
|
$57,825
$771.81 P/Share
|
Jun 04
2025
|
Michael Garnreiter Director |
SELL
Open market or private sale
|
Direct |
5,913
-25.0%
|
$4,493,880
$760.0 P/Share
|
Jun 03
2025
|
Michael Garnreiter Director |
SELL
Bona fide gift
|
Direct |
1,000
-4.06%
|
-
|
Jun 03
2025
|
Michael Garnreiter Director |
SELL
Open market or private sale
|
Direct |
87
-0.35%
|
$66,120
$760.0 P/Share
|
Jun 02
2025
|
Jennifer H Mak Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,150
-6.18%
|
$1,621,100
$754.46 P/Share
|
Jun 02
2025
|
Jeffrey C Kunins CPO & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,928
-4.79%
|
$6,009,424
$758.57 P/Share
|
Jun 02
2025
|
Joshua Isner PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
28,489
-9.53%
|
$21,594,662
$758.57 P/Share
|
Jun 02
2025
|
Brittany Bagley COO & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,876
-12.04%
|
$12,034,008
$758.57 P/Share
|
May 30
2025
|
Cameron Brooks CHIEF REVENUE OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-13.36%
|
$2,220,000
$740.76 P/Share
|
May 29
2025
|
Jeri Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
446
+23.95%
|
-
|
May 29
2025
|
Matthew R Mcbrady Director |
BUY
Grant, award, or other acquisition
|
Direct |
446
+10.17%
|
-
|
May 29
2025
|
Adriane M Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
446
+5.39%
|
-
|
May 29
2025
|
Caitlin Elizabeth Kalinowski Director |
BUY
Grant, award, or other acquisition
|
Direct |
446
+7.8%
|
-
|
May 29
2025
|
Michael Garnreiter Director |
BUY
Grant, award, or other acquisition
|
Direct |
481
+0.96%
|
-
|
May 29
2025
|
Julie A Cullivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
446
+16.98%
|
-
|
May 29
2025
|
Graham Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
446
+12.88%
|
-
|
May 29
2025
|
Erika Nardini Director |
BUY
Grant, award, or other acquisition
|
Direct |
446
+17.22%
|
-
|
May 29
2025
|
Hadi Partovi Director |
BUY
Grant, award, or other acquisition
|
Direct |
446
+0.19%
|
-
|
May 21
2025
|
Joshua Isner PRESIDENT |
SELL
Open market or private sale
|
Direct |
9,905
-0.36%
|
$7,329,700
$740.28 P/Share
|
May 19
2025
|
Caitlin Elizabeth Kalinowski Director |
SELL
Open market or private sale
|
Direct |
1,300
-21.21%
|
$959,400
$738.84 P/Share
|
May 14
2025
|
Matthew R Mcbrady Director |
SELL
Open market or private sale
|
Direct |
400
-10.28%
|
$287,200
$718.4 P/Share
|
May 13
2025
|
Cameron Brooks CHIEF REVENUE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,444
-14.52%
|
$2,493,456
$724.77 P/Share
|
May 13
2025
|
Caitlin Elizabeth Kalinowski Director |
SELL
Open market or private sale
|
Direct |
800
-11.55%
|
$570,400
$713.25 P/Share
|
May 13
2025
|
Brittany Bagley COO & CFO |
SELL
Open market or private sale
|
Direct |
3,400
-2.51%
|
$2,380,000
$700.0 P/Share
|
May 12
2025
|
Julie A Cullivan Director |
SELL
Open market or private sale
|
Direct |
657
-27.47%
|
$459,900
$700.0 P/Share
|
May 12
2025
|
Joshua Isner PRESIDENT |
SELL
Open market or private sale
|
Direct |
9,000
-0.12%
|
$6,138,000
$682.65 P/Share
|
May 12
2025
|
Jeri Williams Director |
SELL
Open market or private sale
|
Direct |
657
-40.38%
|
$459,900
$700.0 P/Share
|
Apr 21
2025
|
Patrick W Smith CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-0.02%
|
$5,430,000
$543.43 P/Share
|